Antihypertensive activity of blueberries fermented by Lactobacillus plantarum DSM 15313 and effects on the gut microbiota in healthy rats

Clinical Nutrition

Volumn 34, Issue 4, 2015, Pages 719-726

  Ahrén, Irini Lazou ^a   Xu, Jie ^b   Önning, Gunilla ^a   Olsson, Crister ^c   Ahrné, Siv ^b   Molin, Göran ^b  

^a Probi AB   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Berries; Hypertension; L NAME; Microbiota; Probiotics

Indexed keywords

HERBACEOUS AGENT; LIPID; PHENOLIC ACID; PLANT MEDICINAL PRODUCT; PROBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIHYPERTENSIVE AGENT; N(G) NITROARGININE METHYL ESTER;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; BLUEBERRY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; FERMENTATION; FREEZE DRYING; HYPERTENSION; INTESTINE FLORA; LACTOBACILLUS PLANTARUM; LIPID BLOOD LEVEL; MALE; NONHUMAN; ORGAN WEIGHT; RAT; TREATMENT DURATION; ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; FRUIT; HEART; KIDNEY; LIVER; METABOLISM; MICROBIOLOGY; ORGAN SIZE; PHYTOTHERAPY; SPLEEN; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLUEBERRY PLANT; BODY WEIGHT; FERMENTATION; FRUIT; GASTROINTESTINAL MICROBIOME; HEART; HYPERTENSION; KIDNEY; LACTOBACILLUS PLANTARUM; LIVER; MALE; NG-NITROARGININE METHYL ESTER; ORGAN SIZE; PHYTOTHERAPY; PLANT PREPARATIONS; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN;

EID: 84930733560     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.08.009     Document Type: Article

References (28)

1. 1999 World Health Organization-International Society of hypertension Guidelines for the management of hypertension. Guidelines Subcommittee. JHypertens 1999, 17(2):151-183.
2. Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120(16):1640-1645.
3. Ried K., Sullivan T., Fakler P., Frank O.R., Stocks N.P. Does chocolate reduce blood pressure? A meta-analysis. BMC Med 2010, 8.
4. Pechanova O., Rezzani R., Babal P., Bernatova I., Andriantsitohaina R. Beneficial effects of provinols (TM): cardiovascular system and kidney. Physiol Res 2006, 55:S17-S30.
5. Kapil V., Milsom A.B., Okorie M., Maleki-Toyserkani S., Akram F., Rehman F., et al. Inorganic nitrate supplementation lowers blood pressure in humans role for nitrite-derived NO. Hypertension 2010, 56(2):274-281.
6. Jauhiainen T., Korpela R. Milk peptides and blood pressure. JNutr 2007, 137(3):825s-829s.
7. FAO/WHO Guidelines for the evaluation of probiotics in food. Joint FAO/WHO working group report on drafting guidelines for the evaluation of probiotics in food 2002.
8. Singh V.P., Sharma J., Babu S., Rizwanulla, Singla A. Role of probiotics in health and disease: a review. JPak Med Assoc 2013, 63(2):253-257.
9. Mikelsaar M., Stsepetova J., Hutt P., Kolk H., Sepp E., Loivukene K., et al. Intestinal Lactobacillus sp is associated with some cellular and metabolic characteristics of blood in elderly people. Anaerobe 2010, 16(3):240-246.
10. Diamant M., Blaak E.E., de Vos W.M. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?. Obes Rev 2011, 12(4):272-281.
11. Cani P.D., Delzenne N.M. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol 2009, 9(6):737-743.
12. Xu J., Ahren I.L., Prykhodko O., Olsson C., Ahrne S., Molin G. Intake of blueberry fermented by Lactobacillus plantarum affects the gut microbiota of L-NAME treated rats. Evid Based Complement Altern Med 2013, 2013:809128.
13. Torok J. Participation of nitric oxide in different models of experimental hypertension. Physiol Res 2008, 57(6):813-825.
14. Hlavackova L., Urbanova A., Ulicna O., Janega P., Cerna A., Babal P. Piperine, active substance of black pepper, alleviates hypertension induced by NO synthase inhibition. Bratisl Lek Listy 2010, 111(8):426-431.
15. Bernatova I., Pechanova O., Babal P., Kysela S., Stvrtina S., Andriantsitohaina R. Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am J Physiol Heart Circ Physiol 2002, 282(3):H942-H948.
16. Pechanova O., Bernatova I., Babal P., Martinez M.C., Kysela S., Stvrtina S., et al. Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. JHypertens 2004, 22(8):1551-1559.
17. Oztasan N., Bulbul A., Eryavuz A., Avci G., Kucukkurt I., Fidan A.F. Effect of Yucca schidigera extract on blood pressure, antioxidant activity and some blood parameters in the L-name-induced hypertensive rats. Ank Univ Veter Fak Derg 2008, 55(3):149-153.
18. Smith A.H., Mackie R.I. Effect of condensed tannins on bacterial diversity and metabolic activity in the rat gastrointestinal tract. Appl Environ Microbiol 2004, 70(2):1104-1115.
19. Comalada M., Camuesco D., Sierra S., Ballester I., Xaus J., Galvez J., et al. Invivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappa B pathway. Eur J Immunol 2005, 35(2):584-592.
20. Jiang S., Yang J., Qian D., Guo J., Shang E.X., Duan J.A., et al. Rapid screening and identification of metabolites of quercitrin produced by the human intestinal bacteria using ultra performance liquid chromatography/quadrupole-time-of-flight mass spectrometry. Arch Pharm Res 2013, 37(2):204-213.
21. Basu A., Rhone M., Lyons T.J. Berries: emerging impact on cardiovascular health. Nutr Rev 2010, 68(3):168-177.
22. Naruszewicz M., Johansson M.L., Zapolska-Downar D., Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr 2002, 76(6):1249-1255.
23. Basu A., Du M., Leyva M.J., Sanchez K., Betts N.M., Wu M., et al. Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. JNutr 2010, 140(9):1582-1587.
24. Shaughnessy K.S., Boswall I.A., Scanlan A.P., Gottschall-Pass K.T., Sweeney M.I. Diets containing blueberry extract lower blood pressure in spontaneously hypertensive stroke-prone rats. Nutr Res 2009, 29(2):130-138.
25. Kristo A.S., Kalea A.Z., Schuschke D.A., Klimis-Zacas D.J. AWild blueberry-enriched diet (Vaccinium angustifolium) improves vascular tone in the adult spontaneously hypertensive rat. JAgric Food Chem 2010, 58(22):11600-11605.
26. Kalea A.Z., Clark K., Schuschke D.A., Klimis-Zacas D.J. Vascular reactivity is affected by dietary consumption of wild blueberries in the Sprague-Dawley rat. JMed Food 2009, 12(1):21-28.
27. Lundberg J.O., Gladwin M.T., Ahluwalia A., Benjamin N., Bryan N.S., Butler A., et al. Nitrate and nitrite in biology, nutrition and therapeutics. Nat Chem Biol 2009, 5(12):865-869.
28. Sobko T., Huang L., Midtvedt T., Norin E., Gustafsson L.E., Norman M., et al. Generation of NO by probiotic bacteria in the gastrointestinal tract. Free Radic Biol Med 2006, 41(6):985-991.